Pathogen Detection and Associated Patient Cha...

In the second episode of this two-part series, Drs. Justin Abbatemarco, Valérie Biousse, and Nancy J. Newman discuss the risk of non-arteritic ischemic optic neuropathy and how to counsel patients around GLP-1 medications. Show transcript: Dr. Justin Abbatemarco: Hello and welcom ...  Show more

In part one of this two-part series, Drs. Justin Abbatemarco, Valérie Biousse, and Nancy J. Newman discuss common myths around non-arteritic ischemic optic neuropathy (NAION). Show transcript: Dr. Justin Abbatemarco: Hello and welcome. This is Justin Abbatemarco, and I just got d ...  Show more

Dr. Gordon Smith talks with Laynie Dratch about integrating genetic testing into patient care for persons with Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) spectrum disorders. Read the related article in Neurology: Clinical Practice.  Disclosures can ...  Show more

<span data-sheets-value= "{"1":2,"2":"The February 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and treatment of immune-mediated neuropathies. This episode features Drs. Stacey Clardy and Ted Burns in conversation with Drs. Luise App ...

Thomas Lewis, author of "The End of Alzheimer's: A Differential Diagnosis Toward a Cure," is a microbiologist with a Ph.D. from MIT. He's done a lot of work on diagnostic testing, and in this interview, we explore how retinal assessment and other laboratory tests can be used t ...

Dr. Stacey Clardy discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis with Dr. Antoine Gavoille. Read the full article in Neurology.